Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive (PH plus ) Chronic Myeloid Leukemia (CML) or PH plus Acute Lymphoblastic Leukemia (ALL): a Pharmacokinetic Study

被引：0

作者：

Hijiya, Nobuko ^{[1
]}

Zwaan, C. Michel ^{[1
]}

Rizzari, Carmelo ^{[1
]}

Foa, Roberto ^{[1
]}

Abbink, Floor ^{[1
]}

Lancaster, Donna ^{[1
]}

Landman-Parker, Judith ^{[1
]}

Millot, Frederic ^{[1
]}

Moppett, John ^{[1
]}

Nelken, Brigitte ^{[1
]}

Ducassou, Stephane ^{[1
]}

Putti, Maria Caterina ^{[1
]}

Tian, Xianbin ^{[1
]}

Sinclair, Karen ^{[1
]}

Santanastasio, Helene ^{[1
]}

Buchbinder, Aby ^{[1
]}

Kearns, Pamela ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA

来源：

PEDIATRIC BLOOD & CANCER | 2017年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

315

引用

页码：S34 / S34

页数：1

共 50 条

[21] Venetoclax (VEN) and tyrosine kinase inhibitor (TKI) combinations in Philadelphia chromosome-positive (Ph plus ) acute myeloid leukemia (AML) and chronic myeloid leukemia myeloid blast phase (CML MBP).
Maiti, Abhishek
Ravandi, Farhad
Cortes, Jorge E.
Jabbour, Elias
Marx, Kayleigh
Daver, Naval Guastad
Garcia-Manero, Guillermo
Konopleva, Marina
Benton, Christopher Brent
Masarova, Lucia
Dinardo, Courtney Denton
Bose, Prithviraj
Naqvi, Kiran
Pierce, Sherry A.
Kantarjian, Hagop M.
Short, Nicholas James
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[22] Immunophenotypic Comparison of Philadelphia Chromosome-Like to Philadelphia Chromosome-Positive (Ph plus ) B-Lymphoblastic Leukemia
Choi, Sarah M.
Shao, Lina
Boyer, Daniel
LABORATORY INVESTIGATION, 2018, 98 : 507 - 508
[23] Immunophenotypic Comparison of Philadelphia Chromosome-Like to Philadelphia Chromosome-Positive (Ph plus ) B-Lymphoblastic Leukemia
Choi, Sarah M.
Shao, Lina
Boyer, Daniel
MODERN PATHOLOGY, 2018, 31 : 507 - 508
[24] PONATINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Narayanan, V.
Pollyea, D. A.
Gutman, J. A.
Jimeno, A.
DRUGS OF TODAY, 2013, 49 (04) : 261 - 269
[25] Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
McCormack, Paul L.
Keam, Susan J.
BIODRUGS, 2012, 26 (01) : 61 - 64
[26] Spotlight on dasatinib in chronic myeloid leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
McCormack P.L.
Keam S.J.
BioDrugs, 2012, 26 (1) : 61 - 64
[27] Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
Ottmann, Oliver G.
Wassmann, Barbara
Pfeifer, Heike
Giagounidis, Aristoteles
Stelljes, Matthias
Duehrsen, Ulrich
Schmalzing, Marc
Wunderle, Lydia
Binckebanck, Anja
Hoelzer, Dieter
CANCER, 2007, 109 (10) : 2068 - 2076
[28] Outcomes with inotuzumab ozogamicin (InO) in patients with Philadelphia chromosome-positive (Ph plus ) relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).
Stock, Wendy
Martinelli, Giovanni
Stelljes, Matthias
DeAngelo, Daniel J.
Gokbuget, Nicola
Advani, Anjali S.
O'Brien, Susan Mary
Liedtke, Michaela
Merchant, Akil Abid
Cassaday, Ryan Daniel
Wang, Tao
Vandendries, Erik
Marks, David I.
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[29] Philadelphia positive (Ph plus ) acute lymphoblastic leukemia (ALL) patient with breast infiltration
Papayannidis, Cristina
Iacobucci, Ilaria
Abbenante, Maria Chiara
Curti, Antonio
Parisi, Sarah
Paolini, Stefania
Testoni, Nicoletta
Baccarani, Michele
Cilloni, Daniela
Martinelli, Giovanni
LEUKEMIA RESEARCH, 2010, 34 (09) : E246 - E247
[30] Prognostic Significance of the Lost of a Major Molecular Response In Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (Ph plus CML)
Valentin Garcia-Gutierrez, J.
Herrera, Pilar
Jimenez-Rolando, Marta
Tenorio, Maria
Calbacho, Maria
Jesus Blanchard, M.
Dolores Rey, Maria
Ramos, Paloma
Ramos, M. L.
Lopez, Javier
BLOOD, 2010, 116 (21) : 1408 - 1408

← 1 2 3 4 5 →